Vinn,
Excellent post and what a progressive coy to be partnership with.
TEVA's no 1 selling drug is its $3 billion multiple sclerosis(MS) drug Copaxone which currently makes up 21% of sales(coming off patent in 2013). So TEVAs acquisition of CEPH now has the merged entity @ $20bn - talk about forward planning by this super Global Pharma.
And if the Cardio Franshise wanst enough, just to make sure that MSB retains its NO 1 'sweetheart' title within the TEVA family, the Blaster is looking at developing an MS application as part of its Intravenous Program /Francshise ( page 5 annual report).
Great 2012 coming on !
Cheers to all holders.
this company is now a substantial holder ...., page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10425 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 44243 | 5 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |